PerkinElmer released new dried blood spot based COVID-19 serology test
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
-
-
GSK and CureVac announced strategic mRNA technology collaboration
On Jul. 21, 2020, GlaxoSmithKline and CureVac announced the signing of a strategic collaboration agreement for the research, development,…
-
Experimental coronavirus vaccine reported safe and produces immune response
On Jul. 21, 2020, researchers announced they were working to develop a safe and effective vaccine against SARS-CoV-2,…
-
Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
-
COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
-
BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
-
Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
-
OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract
On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite…
-
Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
-
Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
On Jul. 20, 2020, Pfizer and BioNTech announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
-
Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
-
Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
On Jul. 20, 2020, Luminex announced the Food and Drug Administration (FDA) had issued an Emergency Use Authorization…
-
Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
-
Biology | Biotechnology | Diagnostics | Imaging | Neurology | NIH | Women's Health
NIH study showed highly reproducible sex differences in aspects of human brain anatomy
On Jul. 20, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…
-
The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
-
FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
On Jul. 20, 2020, Sorrento received clearance from the U.S. Food and Drug Administration (FDA) to initiate a…
-
Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
-
Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19
On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…
-
COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
On Jul. 18, 2020, with Brazil leading the world in newly diagnosed COVID-19 cases, Latin America has become…
-
The FDA FDA Issued first Emergency Authorization for sample pooling in diagnostic testing
On Jul. 18, 2020, the U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to…
-
Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
-
RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
-
Dynavax and Mount Sinai announced collaboration to develop a universal influenza vaccine candidate with CpG 1018 adjuvant
On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…
-
Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTI for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
-
Telesis Bio Releases New Synthetic SARS-CoV-2 Genome for COVID-19 Vaccine and Therapeutic Research
On Jul. 16, 2020, Telesis Bio announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Medical Device | Non-Profit Research | Oncology | Rare Disease | Stem Cell | Therapeutics | U.S. Congress
Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical Times in US
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
-
Atossa Therapeutics contracted for clinical study of AT-301 nasal spray for treating COVID-19
On Jul. 16, 2020, Atossa Therapeutics announced that it had contracted with Avance Clinical Pty to conduct a…
-
WHO and UNICEF warn of a decline in vaccinations during COVID-19
On Jul. 14, 2020, the World Health Organization (WHO) and UNICEF warned of an alarming decline in the…
-
More than 150 countries engaged in COVID-19 vaccine global access facility
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
